Categories AlphaGraphs, Earnings, Health Care
AMGN Earnings: Highlights of Amgen’s Q3 2023 financial results
Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023. The company also provided guidance for fiscal 2023.
Adjusted earnings increased to $4.96 per share in the September quarter from $4.70 per share in the year-ago period. The reported net income was $1.73 billion or $3.22 per share in the latest quarter, compared to $2.14 billion or $3.98 per share in the same period of last year.
Total revenues increased 4% from last year to $6.9 billion during the three-month period. There was a 5% growth in product sales, benefiting from double-digit volume growth.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent
Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1
Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three
After a positive year, what’s in the cards for Electronic Arts (EA) in FY25
Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter. The stock declined following the announcement as earnings
